🔗 Permalink

Inventor profile of:

Nigel R.A. Beeley

City:

Solana Beach, California

Country:

United States

Published Applications:

Last publication date:

2024-09-19

Top Assignees for applications by Nigel R.A. Beeley

The entities that hold a legal rights for patent applications filed by inventor Beeley Nigel R.A.:

Elcelyx Therapeutics, Inc. 14 San Diego, CA United States
Anji Pharma (US) LLC 3 Boxford, MA United States
LIPIDIO PHARMACEUTICALS INC. 2 San Diego, CA United States
Anji Pharmaceuticals Inc. 2 Cambridge, MA United States
GDD Therapeutics, LLC 1 Santa Fe, CA United States
Amylin Pharmaceuticals, Inc. 1 San Diego, CA United States
Astrazeneca Pharmaceuticals LP 1 Wilmington, DE United States
Amylin Pharmaceuticals, LLC 1 San Diego, CA United States

Recent patent applications by Beeley Nigel R.A.

Nigel R.A. Beeley from Solana Beach, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-09-19

US20240307388A1

Human necessities

FORMULATIONS FOR SUBSTITUTED 3-PYRROLIDINES, COMPOSITIONS CONTAINING, AND USES OF SAME

#2 | 2023-09-14

US20230285330A9

Human necessities

Compositions and methods for treating metabolic disorders

#3 | 2022-05-19

US20220151957A1

Human necessities

Biguanide compositions and methods of treating metabolic disorders

#4 | 2020-10-01

US20200306248A1

Human necessities

Methods of treating a patient afflicted with non-alcoholic steatohepatitis (NASH)

#5 | 2020-05-07

US20200138751A1

Human necessities

Biguanide compositions and methods of treating metabolic disorders

#6 | 2019-10-10

US20190307708A1

Human necessities

COMPOSITIONS AND METHODS FOR TREATING METABOLIC DISORDERS

#7 | 2019-03-14

US20190076380A1

Human necessities

Biguanide compositions and methods of treating metabolic disorders

#8 | 2019-02-07

US20190038576A1

Human necessities

Chemosensory receptor ligand-based therapies

#9 | 2017-07-27

US20170209394A1

Human necessities

Biguanide compositions and methods of treating metabolic disorders

#10 | 2017-07-20

US20170202790A1

Human necessities

Biguanide compositions and methods of treating metabolic disorders

#11 | 2017-06-15

US20170165209A1

Human necessities

Compositions comprising statins, biguanides and further agents for reducing cardiometabolic risk

#12 | 2017-01-26

US20170020829A1

Human necessities

Chemosensory receptor ligand-based therapies

#13 | 2015-09-24

US20150265555A1

Human necessities

Chemosensory receptor ligand-based therapies

#14 | 2015-07-16

US20150196509A1

Human necessities

Compositions comprising statins, biguanides and further agents for reducing cardiometabolic risk

#15 | 2015-03-05

US20150064223A1

Human necessities

Biguanide compositions and methods of treating metabolic disorders

#16 | 2014-11-20

US20140341986A1

Chemistry; metallurgy

Biguanide compositions and methods of treating metabolic disorders

#17 | 2014-01-30

US20140030332A1

Human necessities

Chemosensory receptor ligand-based therapies

#18 | 2013-12-19

US20130338095A1

Chemistry; metallurgy

Chemosensory Receptor Ligand-Based Therapies

#19 | 2013-11-14

US20130303466A1

Human necessities

Chemosensory Receptor Ligand-Based Therapies

#20 | 2013-10-24

US20130281394A1

Chemistry; metallurgy

Chemosensory Receptor Ligand-Based Therapies

#21 | 2013-10-24

US20130281387A1

Human necessities

Chemosensory Receptor Ligand-Based Therapies

#22 | 2012-07-12

US20120177730A1

Human necessities

Chemosensory Receptor Ligand-Based Therapies

#23 | 2011-08-11

US20110195904A1

Physics

Methods of treatment using exendin peptides or GLP-1 peptides

InventorID:

498540 ⎘